Prevalence of p53 and p21 Expression in Colorectal Cancer: A Histopathologic Study from Iran

[1]  K. Ghaffarzadegan,et al.  Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features. , 2011, Pakistan journal of biological sciences : PJBS.

[2]  Robin P Boushey,et al.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. , 2009, Clinics in colon and rectal surgery.

[3]  K. Galal,et al.  Inherent Resistance to Epidermal Growth Factor Receptor Antibodies in Refractory Metastatic Colorectal Cancer , 2009 .

[4]  E. Azizi,et al.  Association between p53 expression and Bcl-2, P-glycoprotein, topoisomerase II alpha, thymidylate synthase and thymidine phosphorylase as potential therapeutic targets in colorectal cancer patients. , 2007, Pakistan journal of biological sciences : PJBS.

[5]  G. Jiang,et al.  Level of the Expression of VEGF-A, B, C, D and their Receptors (FLT-1, KDR and FLT-4) and its Correlation with Prognosis in Patients with Colorectal Cancer , 2006 .

[6]  S. Fouladdel,et al.  Correlation Between Thymidine Phosphorylase Expression and Sex of Patients in Colorectal Carcinoma , 2005 .

[7]  R. Broll,et al.  p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance? , 2002, International Journal of Colorectal Disease.

[8]  S. Baldus,et al.  Prognostic impact of p21/waf1/cip1 in colorectal cancer , 2000, International journal of cancer.

[9]  G. Viale,et al.  p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations , 1999, The Journal of pathology.